Related news from
Sun, 21 Apr 2024 14:39:58 +0000	11 Best Low Price Pharma Stocks To Invest In In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]
Mon, 25 Mar 2024 11:58:26 +0000	Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68% While Dynavax Technologies Corporation ( NASDAQ:DVAX ) shareholders are probably generally happy, the stock hasn't had...
Tue, 05 Mar 2024 04:53:58 +0000	Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX) Justin Burgess, the Chief Accounting Officer of Dynavax Technologies Corp (NASDAQ:DVAX), has sold 20,526 shares of the company on March 1, 2024, according to a recent SEC Filing.
Tue, 05 Mar 2024 01:28:43 +0000	11 Best Small Cap Pharma Stocks to Invest In In this piece, we will take a look at the 11 best small cap pharma stocks to invest in. If you want to skip our overview of the global pharmaceutical and healthcare industry, which is one the most unique sectors in the world, then you can check out 5 Best Small Cap Pharma Stocks to […]
Tue, 27 Feb 2024 23:54:00 +0000	Dynavax to Present at TD Cowen's 44th Annual Health Care Conference Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at TD Cowen's 44th Annual Health Care Conference on Monday, March 4 at 10:30 a.m. ET.
Fri, 23 Feb 2024 15:34:42 +0000	Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript February 22, 2024 Dynavax Technologies Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day ladies and gentlemen and welcome to the Dynavax Technologies’ Fourth Quarter and Full Year 2023 […]
Fri, 23 Feb 2024 11:38:31 +0000	Q4 2023 Dynavax Technologies Corp Earnings Call Q4 2023 Dynavax Technologies Corp Earnings Call
Fri, 23 Feb 2024 01:00:16 +0000	Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript DVAX earnings call for the period ending December 31, 2023.
Thu, 22 Feb 2024 22:15:09 +0000	Dynavax Technologies (DVAX) Reports Break-Even Earnings for Q4 Dynavax Technologies (DVAX) delivered earnings and revenue surprises of 100% and 1%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Thu, 22 Feb 2024 21:44:42 +0000	Dynavax Technologies Corp (DVAX) Reports Robust Revenue Growth and Market Leadership in 2023 Revenue Growth: HEPLISAV-B net product revenue surged by 69% year-over-year to $213 million in 2023. Market Leadership: Achieved market leader status in retail pharmacy and IDNs, with U.S. market share rising to approximately 42%. 2024 Outlook: HEPLISAV-B net product revenue projected to be $265 - $280 million; company expects to be cash flow positive.
Thu, 22 Feb 2024 21:01:00 +0000	Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results for the fourth quarter and full year ended December 31, 2023.
Thu, 08 Feb 2024 21:15:00 +0000	Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024 Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report fourth quarter and full year 2023 financial results on Thursday, February 22, 2024, after the U.S. financial markets close.
Tue, 09 Jan 2024 03:58:10 +0000	3 Stocks Set to Soar 68% to 200% Higher After hitting new all-time highs in 2023, the S&P 500 is off to a slower start this year. The broad-based index is down 1.5% in the first week of trading. The first jobs report of the new year showed strong gains, which could cause the Federal Reserve to stand firm on the high interest rates it jacked up last year. That could make for a slower-growing economy in 2024. This backdrop has led to the stock picks to buy. But no one knows which way it will really go so it’s best not to try and time. S
Mon, 08 Jan 2024 14:00:00 +0000	Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced preliminary, unaudited financial highlights for the fourth quarter and full year ended December 31, 2023.
Fri, 05 Jan 2024 13:50:06 +0000	Dynavax Technologies (DVAX) Is a Great Choice for 'Trend' Investors, Here's Why Dynavax Technologies (DVAX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Fri, 05 Jan 2024 08:03:30 +0000	Insider Sell: Dynavax Technologies Corp President & COO David Novack Sells 9,000 Shares David Novack, President & COO of Dynavax Technologies Corp (NASDAQ:DVAX), sold 9,000 shares of the company on January 2, 2024, according to a recent SEC filing.
Thu, 04 Jan 2024 15:40:00 +0000	Collegium (COLL) Shares Rise on Financial Outlook for 2024 Collegium (COLL) reports financial guidance for full-year 2024 and business updates. Shares of the company rise on the same.
Thu, 04 Jan 2024 14:46:00 +0000	Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO Assertio (ASRT) appoints Heather Mason as its interim CEO as its current CEO, Dan Peisert, steps down from his role. Shares of the company fall on the same.
Wed, 03 Jan 2024 23:33:00 +0000	Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11 at 11:15 a.m. PT.
Wed, 03 Jan 2024 17:32:38 +0000	Is Dynavax Technologies Corporation's (NASDAQ:DVAX) Recent Stock Performance Influenced By Its Financials In Any Way? Dynavax Technologies' (NASDAQ:DVAX) stock up by 3.3% over the past month. As most would know, long-term fundamentals...